Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

A surge in deals and financings had the industry abuzz heading into this year’s J.P. Morgan Healthcare Conference. But some ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

The average one-year price target for MAIA Biotechnology (NYSEAM:MAIA) has been revised to $10.48 / share. This is a decrease ...

Venture capitalists point to a surge in M&A and a glint of revival in the IPO arena as signs of better days ahead.

Explore India's potential in futuristic marine and space biotechnology to enhance biomanufacturing and strengthen its ...

An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...

A successful Phase 3 trial and a public offeringof stock boosted prospects for this company to receive approval for an ...

Eastern North Carolina's biomanufacturing sector is experiencing unprecedented growth, with the region capturing the lion's ...

SOLSTICE trial data demonstrate that 66% of chronic hepatitis delta participants receiving a monthly dose of tobevibart and elebsiran achieved undetectable HDV RNA at Week 48 Combination ...

Shares of Theratechnologies (NASDAQ:THTX) rose after the company announced on Thursday that it will be acquired by CB Biotechnology, a subsidiary of Future Pak, in a deal valued at $254M. CB ...